drm02
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2013 (NCT01993446)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Phosphodiesterase 4AINHIBITOR
EEF1A1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- drm02
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01993420 | Phase 2 | Oct 1, 2013 | Dermira, Inc. |
| NCT01993433 | Phase 2 | Oct 1, 2013 | Dermira, Inc. |
| NCT01993446 | Phase 2 | Oct 1, 2013 | Dermira, Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Dermira, Inc. | For profit | 3 | 3 | 1 | 2013 |
1 organizations
Page 1 / 1